US Stock MarketDetailed Quotes

SPRC SciSparc

Watchlist
  • 0.2328
  • +0.0195+9.14%
Close Dec 23 16:00 ET
  • 0.2249
  • -0.0079-3.39%
Post 19:50 ET
2.41MMarket Cap-0.04P/E (TTM)

About SciSparc Company

SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The firm initiated two internal drug development programs based on repurposing an FDA approved synthetic cannabinoid (dronabinol): Joint Pharma developing THX-TS01 targeted to the treatment of TS and Brain Bright Pharma developing THX-ULD01 targeted to the high value and under-served market of MCIs. Its products include SCI-110, SCI-210, SCI-160, and CannAmide. The company was founded on August 23, 2004 and is headquartered in Tel Aviv, Israel.

Company Profile

SymbolSPRC
Company NameSciSparc
Founded2004
CEOMr. Oz Adler, C.P.A.
MarketNASDAQ
Employees3
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
Address20 Raul Wallenberg Street`,Tower A,2nd Floor
CityTel Aviv
ProvinceTel Aviv
CountryIsrael
Zip Code6971916
Phone972-3-717-5777
Websitehttp://www.scisparc.com

Company Executives

  • Name
  • Position
  • Salary
  • Oz Adler, C.P.A.
  • Chief Executive Officer and Chief Financial Officer
  • 379.00K
  • Dr. Adi Zuloff-Shani
  • Chief Technologies Officer
  • 296.00K
  • Itschak Shrem
  • President and Director
  • 235.00K
  • Amitay Weiss
  • Chairman of the Board
  • 235.00K
  • Lior Vider
  • Independent Director
  • 29.00K
  • Moshe Revach
  • Independent Director
  • --
  • Amnon Ben Shay
  • Independent Director
  • --
  • Liat Sidi
  • Independent Director
  • --
  • Alon Dayan
  • Independent Director
  • --
Heat List
US
Overall
Symbol
Price
% Chg

No Data